Longeveron Appoints Wa'el Hashad as Chief Executive Officer

Stock Information for Longeveron Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Longeveron Inc.

Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B(TM) in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)
Longeveron Announces Closing of $5.2 Million Public Offering
Longeveron Announces Pricing of $5.25 Million Public Offering
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
Longeveron Announces 1-for-10 Reverse Stock Split
Longeveron Reports Year-End 2023 Results and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.